受强制性开放获取政策约束的文章 - Brian Werth了解详情
可在其他位置公开访问的文章：31 篇
Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a …
BJ Werth, G Sakoulas, WE Rose, J Pogliano, R Tewhey, MJ Rybak
Antimicrobial Agents and Chemotherapy 57 (1), 66-73, 2013
强制性开放获取政策： US National Institutes of Health
Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a …
BJ Werth, R Jain, A Hahn, L Cummings, T Weaver, A Waalkes, ...
Clinical Microbiology and Infection 24 (4), 429. e1-429. e5, 2018
强制性开放获取政策： US National Institutes of Health
Multidrug-resistant Corynebacterium striatum associated with increased use of parenteral antimicrobial drugs
WO Hahn, BJ Werth, SM Butler-Wu, RM Rakita
Emerging Infectious Diseases 22 (11), 1908, 2016
强制性开放获取政策： US National Institutes of Health
Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA
BJ Werth, C Vidaillac, KP Murray, KL Newton, G Sakoulas, P Nonejuie, ...
Antimicrobial agents and chemotherapy 57 (5), 2376-2379, 2013
强制性开放获取政策： US National Institutes of Health
Evaluation of ceftaroline activity against heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-intermediate methicillin-resistant S. aureus strains in …
BJ Werth, ME Steed, GW Kaatz, MJ Rybak
Antimicrobial agents and chemotherapy 57 (6), 2664-2668, 2013
强制性开放获取政策： US National Institutes of Health
Antimicrobial use across six referral hospitals in Tanzania: a point prevalence survey
J Seni, SG Mapunjo, R Wittenauer, R Valimba, A Stergachis, BJ Werth, ...
BMJ open 10 (12), e042819, 2020
强制性开放获取政策： US National Institutes of Health, US Agency for International Development
Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis
BJ Werth, ME Steed, CE Ireland, TT Tran, P Nonejuie, BE Murray, ...
Antimicrobial Agents and Chemotherapy 58 (9), 5253-5261, 2014
强制性开放获取政策： US National Institutes of Health
Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
KE Barber, BJ Werth, CE Ireland, NE Stone, P Nonejuie, G Sakoulas, ...
Journal of Antimicrobial Chemotherapy 69 (11), 3006-3010, 2014
强制性开放获取政策： US National Institutes of Health
Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro …
BJ Werth, KE Barber, CE Ireland, MJ Rybak
Antimicrobial agents and chemotherapy 58 (6), 3177-3181, 2014
强制性开放获取政策： US National Institutes of Health
Emergence of high-level daptomycin resistance in Corynebacterium striatum in two patients with left ventricular assist device infections
BJ Werth, WO Hahn, SM Butler-Wu, RM Rakita
Microbial Drug Resistance 22 (3), 233-237, 2016
强制性开放获取政策： US National Institutes of Health
Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model
AD Hall Snyder, BJ Werth, P Nonejuie, JP McRoberts, J Pogliano, ...
Antimicrobial Agents and Chemotherapy 60 (10), 5716-5723, 2016
强制性开放获取政策： US National Institutes of Health
A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant …
KE Barber, BJ Werth, JP McRoberts, MJ Rybak
Antimicrobial agents and chemotherapy 58 (5), 2989-2992, 2014
强制性开放获取政策： US National Institutes of Health
The combination of ceftaroline plus daptomycin allows for therapeutic de-escalation and daptomycin sparing against MRSA
KE Barber, BJ Werth, MJ Rybak
Journal of Antimicrobial Chemotherapy 70 (2), 505-509, 2015
强制性开放获取政策： US National Institutes of Health
National consumption of antimicrobials in Tanzania: 2017–2019
R Mbwasi, S Mapunjo, R Wittenauer, R Valimba, K Msovela, BJ Werth, ...
Frontiers in Pharmacology 11, 585553, 2020
强制性开放获取政策： US National Institutes of Health, US Agency for International Development
Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide-and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels
KM Hines, T Shen, NK Ashford, A Waalkes, K Penewit, EA Holmes, ...
Journal of Antimicrobial Chemotherapy 75 (5), 1182-1186, 2020
强制性开放获取政策： US National Institutes of Health
Dalbavancin exposure in vitro selects for dalbavancin-non-susceptible and vancomycin-intermediate strains of methicillin-resistant Staphylococcus aureus
BJ Werth, NK Ashford, K Penewit, A Waalkes, EA Holmes, DH Ross, ...
Clinical Microbiology and Infection 27 (6), 910. e1-910. e8, 2021
强制性开放获取政策： US National Institutes of Health
Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus …
ME Steed, BJ Werth, CE Ireland, MJ Rybak
Antimicrobial agents and chemotherapy 56 (11), 5709-5714, 2012
强制性开放获取政策： US National Institutes of Health
New perspectives on antimicrobial agents: long-acting lipoglycopeptides
TT Tran, S Gomez Villegas, SL Aitken, SM Butler-Wu, A Soriano, BJ Werth, ...
Antimicrobial Agents and Chemotherapy 66 (6), e02614-20, 2022
强制性开放获取政策： US National Institutes of Health
Emergence of Dalbavancin, Vancomycin, and Daptomycin Nonsusceptible Staphylococcus aureus in a Patient Treated With Dalbavancin: Case Report and Isolate …
R Zhang, H Polenakovik, IA Barreras Beltran, A Waalkes, SJ Salipante, ...
Clinical Infectious Diseases 75 (9), 1641-1644, 2022
强制性开放获取政策： US National Institutes of Health
Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques
BJ Werth, NK Ashford, K Penewit, A Waalkes, EA Holmes, A Bryan, ...
JAC-Antimicrobial Resistance 4 (1), dlac011, 2022
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定